Improving Metabolic Health and amp; Reducing the Total Cost of Care In a world where 42% of people are living with obesity, and 95% of diets fail, we need a new approach. A new class of medications, GLP-1s, demonstrate 15% weight loss, are indicated for ~70% of the population, and cost and gt; $10,000 per year. A wave of similar options will soon be approved and with them, pharmacy claims costs are expected to dwarf the national diabetes spend over the next 5-10 years. Calibrate is changing the way the world treats weight with our purpose-built platform that delivers the right medication for the right length of time in combination with intensive lifestyle intervention to solve for both outcomes and cost. Download the program preview to learn how Calibrate’s program can deliver a dual benefit for your organization—solving for metabolic health and medication costs.
Introducing Calibrate: The Next-Generation Of Obesity Treatment
